gastric cancer
Showing NaN - NaN of 39
Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,
Active, not recruiting
- Gastric Cancer
- +2 more
- margetuximab
- +4 more
-
Scottsdale, Arizona
- +72 more
Aug 24, 2022
Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)
Active, not recruiting
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Pembrolizumab
- +7 more
-
Duarte, California
- +170 more
Aug 18, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in Worldwide (Bavituximab, Pembrolizumab Injection)
Active, not recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- Bavituximab
- Pembrolizumab Injection
-
New Haven, Connecticut
- +20 more
Jun 14, 2022
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Gastro-Esophageal Junction Adenocarcinoma, Gastric Cancer Trial in United States (Nab-paclitaxel 150 mg/m^2, Oxaliplatin 85
Active, not recruiting
- Gastro-Esophageal Junction Adenocarcinoma
- Gastric Cancer
- Nab-paclitaxel 150 mg/m^2
- +3 more
-
Chicago, Illinois
- +7 more
Feb 16, 2022
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021
Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)
Active, not recruiting
- Metastatic Cancer
- +4 more
- VE800
- +2 more
-
Scottsdale, Arizona
- +17 more
Jun 22, 2021
Multi-Media Tool on Enrollment in Oncology Clinical Trials
Completed
- Lung Cancer
- +2 more
- Testing an interactive technology in a diverse health literary population
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Mar 8, 2021
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Capecitabine, Cisplatin)
Gastric Cancer Trial in Canada, United States (S-1/Cisplatin, 5-FU/cisplatin)
Completed
- Gastric Cancer
-
Huntsville, Alabama
- +32 more
Aug 4, 2020
Esophageal Cancer, Gastric Cancer Trial in Los Angeles, Chicago, Portland (irinotecan HCl, paclitaxel)
Completed
- Esophageal Cancer
- Gastric Cancer
- irinotecan hydrochloride
- paclitaxel
-
Los Angeles, California
- +3 more
Jul 30, 2020
Esophageal Cancer, Gastric Cancer Trial in Canada, United States (cisplatin, epirubicin HCl, fluorouracil)
Completed
- Esophageal Cancer
- Gastric Cancer
- cisplatin
- +4 more
-
Anniston, Alabama
- +534 more
Apr 28, 2020
NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)
Completed
- NSCLC
- Gastric Cancer
-
Birmingham, Alabama
- +27 more
Jan 24, 2020
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer Trial in United States (FOLFOX regimen,
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FOLFOX regimen
- +5 more
-
Mobile, Alabama
- +507 more
Oct 25, 2019
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer Trial in United States (procedure, drug,
Terminated
- Adenocarcinoma of the Gastroesophageal Junction
- +2 more
- FDG-PET
- +7 more
-
Los Angeles, California
- +70 more
Sep 10, 2019
Gastric Cancer, Solid Tumor Trial in Chicago (docetaxel, fluorouracil, oxaliplatin)
Completed
- Gastric Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- docetaxel
- +2 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Feb 5, 2019
Gastric Cancer Trial in Worldwide (Placebo, Onartuzumab (MetMAb), Oxaliplatin)
Completed
- Gastric Cancer
- Placebo
- +5 more
-
Denver, Colorado
- +35 more
Aug 4, 2016